Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (241-250 of 330) with videos related to

Pageof 33
Sort By:
Nature Medicine|December 9, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al.
JCI Insight|February 3, 2026
The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic disseminationTarek Taifour, Adéline Massé, Yu Gu, et al.
Breast Cancer Research and Treatment|July 30, 2022
Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivorsRachel A Freedman, Anna C Revette, Haley Gagnon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2022
Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship CareAntonio Di Meglio, Julie Havas, Davide Soldato, et al.
Neuro-Oncology|February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
Neuro-Oncology|August 22, 2020
Response to Letter to EditorTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
NPJ Breast Cancer|December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastasesKatarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
Pageof 33

Showing results (241-250 of 330) with videos related to

Sort By:
Pageof 33
Nature Medicine|December 9, 2024
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al.
JCI Insight|February 3, 2026
The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic disseminationTarek Taifour, Adéline Massé, Yu Gu, et al.
Breast Cancer Research and Treatment|July 30, 2022
Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivorsRachel A Freedman, Anna C Revette, Haley Gagnon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2022
Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship CareAntonio Di Meglio, Julie Havas, Davide Soldato, et al.
Neuro-Oncology|February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)Nancy U Lin, Hao Guo, Jeffrey T Yap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.
Neuro-Oncology|August 22, 2020
Response to Letter to EditorTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
NPJ Breast Cancer|December 20, 2025
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastasesKatarzyna J Jerzak, Evangelia D Razis, Elisa Agostinetto, et al.
Pageof 33